Tagged: therapeutics

Shuvo Roy, PhD

Professor

I am a bioengineer working on medical device development to address clinical needs by leveraging my background in MEMS (microelectromechanical systems) along with advances in biomaterials, electronics, and nanotechnology to advance health world-wide.

Kathy Giacomini, PhD

Professor & CERSI Co-Director

My research focuses on membrane transporters, which are of great importance to drug disposition and response. I am particularly interested in genetic variants in membrane transporters that are determinants of drug response and in harnessing transporters to enhance drug targeting. 

School of Pharmacy biotech symposium features case histories of future pharmaceuticals

The 2nd Annual Bay Area Biotechnology Symposium, presented by the UCSF School of Pharmacy’s Industry Outreach Program in coordination with the UCSF Postdoctoral Scholars Association at Mission Bay in late May 2011, fully lived up to its billing: “Pharmaceuticals of the Future: Case Histories and Challenges.”

Symposium on the future of therapeutics inaugurates new UCSF department

In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics and therapeutics to effectively and safely diagnose and treat disease.

Two Circuits Found Responsible for a Cell's Ability to Adapt

UCSF researchers have identified the two key circuits, compared to hundreds as previously thought, that control a cell's ability to adapt to changes in its environment. These circuits are key to a cell's ability to reset itself after responding to a stimulus.

New Department of Bioengineering and Therapeutic Sciences

The UCSF Department of Bioengineering and Therapeutic Sciences, which is UCSF's first department administered jointly by two schools, was announced today to the campus community by UCSF Chancellor J. Michael Bishop, MD.